Suhardjono D, Boutagy J, Shenfield G M
Br J Clin Pharmacol. 1986 Oct;22(4):401-8. doi: 10.1111/j.1365-2125.1986.tb02909.x.
Forty-nine healthy volunteers (47 male, 2 female) had their sulphadimidine acetylator status determined on a control day and on a second occasion when they were given an oral glucose load. They were classified as fast and slow acetylators using the standard urine method and as fast, slow and intermediate acetylators using calculated metabolic and total body clearances. Twenty-seven (55%) were slow acetylators and this proportion was not altered by glucose loading either with or before sulphadimidine ingestion. On the control day, five (10%) were fast and 17 (35%) were intermediate acetylators but these sub-groups were not clearly distinguishable from each other when glucose was given. The glucose load did not cause any individual to change from slow to fast categories. Two type 2 (insulin independent) diabetics also showed no difference in acetylator status when studied with widely different blood glucose concentrations. We conclude that glucose can induce minor increases in sulphadimidine clearance but is unlikely to alter phenotypic acetylation status. Previous observations of an increased incidence of fast acetylators in diabetics may therefore indicate a genetic marker.
49名健康志愿者(47名男性,2名女性)在一个对照日以及在给予口服葡萄糖负荷后的第二个时间点测定了其磺胺二甲嘧啶乙酰化状态。使用标准尿液方法将他们分为快速乙酰化者和慢速乙酰化者,使用计算得出的代谢清除率和全身清除率将他们分为快速、慢速和中间型乙酰化者。27人(55%)为慢速乙酰化者,该比例在磺胺二甲嘧啶摄入时或摄入前给予葡萄糖负荷后均未改变。在对照日,5人(10%)为快速乙酰化者,17人(35%)为中间型乙酰化者,但给予葡萄糖时,这些亚组之间没有明显区别。葡萄糖负荷并未导致任何个体从慢速类别转变为快速类别。两名2型(非胰岛素依赖型)糖尿病患者在血糖浓度差异很大时进行研究,其乙酰化状态也没有差异。我们得出结论,葡萄糖可导致磺胺二甲嘧啶清除率略有增加,但不太可能改变表型乙酰化状态。因此,先前观察到的糖尿病患者中快速乙酰化者发生率增加可能表明存在一种遗传标记。